4//SEC Filing
CANCER GENETICS, INC 4
Accession 0000905718-15-000535
CIK 0001349929operating
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 6:15 PM ET
Size
9.6 KB
Accession
0000905718-15-000535
Insider Transaction Report
Form 4
Chaganti Raju S.K.
Director
Transactions
- Sale
Common Stock, par value $0.0001 per share
2015-06-11$12.05/sh−15,900$191,519→ 137,523 total - Sale
Common Stock, par value $0.0001 per share
2015-06-10$12.03/sh−22,817$274,400→ 153,423 total - Sale
Common Stock, par value $0.0001 per share
2015-06-09$12.01/sh−7,737$92,944→ 176,240 total
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b-5-1 trading plan.
- [F2]The price reported in Column 4 is a weighted average price. These shares were exercised in multiple transactions at prices ranging from $12.00 to $12.05, inclusive. The reporting person undertakes to provide Cancer Genetics, Inc., any security holder of Cancer Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares exercised at each separate price within the ranges set forth in footnote (2) to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were exercised in multiple transactions at prices ranging from $12.00 to $12.15, inclusive. The reporting person undertakes to provide Cancer Genetics, Inc., any security holder of Cancer Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares exercised at each separate price within the ranges set forth in footnote (3) to this Form 4.
- [F4]The price reported in Column 4 is a weighted average price. These shares were exercised in multiple transactions at prices ranging from $12.00 to $12.16, inclusive. The reporting person undertakes to provide Cancer Genetics, Inc., any security holder of Cancer Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares exercised at each separate price within the ranges set forth in footnote (4) to this Form 4.
Documents
Issuer
CANCER GENETICS, INC
CIK 0001349929
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001349929
Filing Metadata
- Form type
- 4
- Filed
- Jun 10, 8:00 PM ET
- Accepted
- Jun 11, 6:15 PM ET
- Size
- 9.6 KB